EAU24 Interview丨Dr. Junlong Zhuang and Dr. Bertrand Tombal jointly interpret the ARASENS study and explore intensive treatment strategies for mHSPC
Editor's note: In recent years, on the basis of androgen deprivation therapy (ADT), new endocrine therapies such as AR pathway inhibitors have become standard treatments for patients with metastatic hormone-sensitive…